Evidence map›Paper›PMID 40450640›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

The impact of COVID-19 pandemic on cancer patients' health and healthcare: findings from a cross-sectional survey on more than 3000 patients.

Hani AziziKia, Armita Farid, Patrick Fazeli, Seyed Sina Sabbaghi, Solmaz Talebi, Zahra Sarvestani, Seyed Mohammad Amin Dashti, Ata Rahbari Farzou, Babak Ehsani Zunuz, Vahid Kia

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hani AziziKiaStudent Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. drhaniazizikia@gmail.com.
Armita FaridIran University of Medical Sciences, Tehran, Iran.
Patrick Fazeli, Agoura Hills, USA.
Seyed Sina SabbaghiGarmsar Branch, Islamic Azad University, Semnan, Iran.
Solmaz TalebiDepartment of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
Zahra SarvestaniSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Seyed Mohammad Amin DashtiSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ata Rahbari FarzouSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Babak Ehsani ZunuzSchool of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Vahid KiaDepartment of Medical Biotechnology, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran. vahidkiaa@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare for cancer patients is one of the greatest challenges facing the medical community during the COVID-19 pandemic. The objective of this study was to investigate the effects of COVID-19 pandemic on cancer patients' health and healthcare.

methodsIn this cross-sectional study, we evaluated and compared gender, symptoms, laboratory values, mortality, and ICU admission of COVID-19-positive and COVID-19-negative cancer patients in Shahroud and Mayamey from June 2020 to May 2021.

resultsNo statistically significant gender disparity was observed in the distribution of COVID-19-positive cancer patients. There was no correlation between age, gender, or lymphocyte count and mortality in these patients. COVID-19 patients with cancer required ICU admission more frequently than those without cancer. In terms of clinical symptoms, no significant differences were observed between the former groups, except that myalgia and arthralgia were less prevalent and mental status deterioration was more prevalent among COVID-19 patients with cancer. In comparison to COVID-19-negative cancer patients, COVID-19-positive cancer patients had significantly lower platelet counts and significantly higher blood sugar levels.

conclusionsThe coexistence of COVID-19 and cancer increases the risk of ICU admission and mortality, and makes patients susceptible to mental status deterioration, thrombocytopenia, and hyperglycemia.

Indexed as

COVID-19NeoplasmsAdultAgedCross-Sectional StudiesFemaleHumansIntensive Care UnitsIranMaleMiddle AgedSARS-CoV-2CancerCOVID-19Mental statusMortality

Identifiers

PMID40450640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.